Qiagen N.v. (QGEN) Financial Statements

Executive TeamFinancials

Qiagen financial statements at a glance

Qiagen reported revenue of $2.09 billion for fiscal year 2025 (ended December 31, 2025), up 5.7% from fiscal year 2024. Net income was $424.88 million, a net margin of 20.3%, and diluted earnings per share were $2.04.

At the end of fiscal year 2025 it had total assets of $6.28 billion, total liabilities of $2.50 billion and shareholders' equity of $3.78 billion, with cash and short-term investments of $1.10 billion and total debt of $1.81 billion.

Its operations brought in $654.33 million of cash; capital spending was $207.13 million, leaving free cash flow of $447.20 million.

The tables below show the income statement, balance sheet and cash flow statement; the key figures of the last 5 fiscal years are at the bottom of the page.

Figures from company filings, in USD; latest fiscal year ended December 31, 2025.

QGEN logo

Qiagen N.v.

QGENNetherlands
Healthcare
USD (Local)

Income Statement

Annual • USD

Total Revenue
2.09B
Prev Year: 1.98B
YoY: +5.7%
Operating Revenue
2.09B
Prev Year: 1.98B
YoY: +5.7%
Net Income from Continuing Operation Net Minority Interest
424.88M
Prev Year: 83.59M
YoY: +408.3%
Total Unusual Items Excluding Goodwill
-54.46M
Prev Year: -102.19M
YoY: +46.7%
Total Unusual Items
-54.46M
Prev Year: -102.19M
YoY: +46.7%
Normalized EBITDA
771.73M
Prev Year: 470.44M
YoY: +64.0%
Tax Rate for Calcs
0.133
Prev Year: 0
Tax Effect of Unusual Items
-7.24M
Prev Year: -31.68M
YoY: +77.1%
Depreciation Amortization Depletion
8.00M
Prev Year: 9.60M
YoY: -16.6%
Depreciation and amortization
8.00M
Prev Year: 9.60M
YoY: -16.6%
Amortization
8.00M
Prev Year: 9.60M
YoY: -16.6%
Amortization of Intangibles
8.00M
Prev Year: 9.60M
YoY: -16.6%
Selling and Marketing Expense
457.99M
Prev Year: 450.93M
YoY: +1.6%
General and Administrative Expense
125.68M
Prev Year: 113.43M
YoY: +10.8%
Other General and Administrative
125.68M
Prev Year: 113.43M
YoY: +10.8%
Cost of Revenue
790.50M
Prev Year: 1.01B
YoY: -21.8%
Gross Profit
1.30B
Prev Year: 967.35M
YoY: +34.3%
Operating Expense
779.18M
Prev Year: 767.45M
YoY: +1.5%
Selling General and Administrative
583.67M
Prev Year: 564.36M
YoY: +3.4%
Research and Development
187.52M
Prev Year: 193.49M
YoY: -3.1%
Operating Income
520.31M
Prev Year: 199.90M
YoY: +160.3%
Net Non Operating Interest Income Expense
31.06M
Prev Year: 24.18M
YoY: +28.5%
Non-operating Interest Income
64.32M
Prev Year: 68.02M
YoY: -5.4%
Non-operating Interest Expense
33.26M
Prev Year: 43.84M
YoY: -24.1%
Other Income Expense
-61.11M
Prev Year: -102.93M
YoY: +40.6%
Special Income Charges
-54.46M
Prev Year: -102.19M
YoY: +46.7%
Restructuring and Mergers Acquisition
54.46M
Prev Year: 102.19M
YoY: -46.7%
Other Non-operating Income (expense)
-6.65M
Prev Year: -739.0K
YoY: -799.9%
Pre-tax Income
490.26M
Prev Year: 121.15M
YoY: +304.7%
Provision for Income Taxes
65.39M
Prev Year: 37.56M
YoY: +74.1%
Net Income Common Stockholders
424.88M
Prev Year: 83.59M
YoY: +408.3%
Net Income
424.88M
Prev Year: 83.59M
YoY: +408.3%
Net Income Including Non-Controlling Interests
424.88M
Prev Year: 83.59M
YoY: +408.3%
Net Income from Continuing Operations
424.88M
Prev Year: 83.59M
YoY: +408.3%
Diluted NI Available to Com Stockholders
424.88M
Prev Year: 83.59M
YoY: +408.3%
Basic EPS
2.062
Diluted EPS
2.042
Weighted Average Shares (basic)
206.07M
Weighted Average Shares (diluted)
207.94M
Total Operating Income as Reported
465.85M
Prev Year: 97.71M
YoY: +376.8%
Total Expenses
1.57B
Prev Year: 1.78B
YoY: -11.7%
Net Income from Continuing and Discontinued Operation
424.88M
Prev Year: 83.59M
YoY: +408.3%
Normalized Income
472.10M
Prev Year: 154.10M
YoY: +206.4%
Interest Income
64.32M
Prev Year: 68.02M
YoY: -5.4%
Interest Expense
33.26M
Prev Year: 43.84M
YoY: -24.1%
Net Interest Income
31.06M
Prev Year: 24.18M
YoY: +28.5%
EBIT
523.52M
Prev Year: 164.99M
YoY: +217.3%
EBITDA
717.27M
Prev Year: 368.26M
YoY: +94.8%
Reconciled Cost of Revenue
604.76M
Prev Year: 817.19M
YoY: -26.0%
Reconciled Depreciation
193.75M
Prev Year: 203.27M
YoY: -4.7%
Values in USD

Qiagen key figures by fiscal year

FY2025FY2024FY2023FY2022FY2021
Revenue$2.1B$2.0B$2.0B$2.1B$2.3B
Gross profit$1.3B$967.4M$1.2B$1.4B$1.5B
Operating income$520.3M$199.9M$445.2M$576.2M$657.8M
Net income$424.9M$83.6M$341.3M$423.2M$512.6M
Diluted EPS$2.04–$1.57$2.65$2.34
Total assets$6.3B$5.7B$6.1B$6.3B$6.1B
Total liabilities$2.5B$2.1B$2.3B$2.8B$3.1B
Shareholders' equity$3.8B$3.6B$3.8B$3.5B$3.1B
Cash and short-term investments$1.1B$1.2B$1.1B$1.4B$1.1B
Total debt$1.8B$1.4B$1.5B$1.9B$2.0B
Operating cash flow$654.3M$673.6M$459.5M$715.3M$639.0M
Capital spending$207.1M$171.2M$162.8M$149.3M$206.5M
Free cash flow$447.2M$502.3M$296.7M$565.9M$432.5M

In USD. Fiscal years as reported by the company; statements on this page go back to fiscal year 2014.

Questions and answers

What was Qiagen's revenue in fiscal year 2025?

$2.09 billion, up 5.7% from $1.98 billion in fiscal year 2024.

How much profit does Qiagen make?

Qiagen reported net income of $424.88 million for fiscal year 2025 (20.3% of revenue); operating income was $520.31 million.

How much cash and debt does Qiagen have?

At the end of fiscal year 2025: cash and short-term investments of $1.10 billion and total debt of $1.81 billion.

What is Qiagen's free cash flow?

$447.20 million in fiscal year 2025 (operating cash flow of $654.33 million minus capital spending of $207.13 million).

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
LinkedInLinkedInXXYouTubeYouTube